Intra-arterial thrombectomy: does invasive treatment lead to better outcomes than intravenous thrombolysis alone?

Abstract

Intravenous thrombolysis is considered to be standard of care for acute ischemic stroke patients arriving within 3-4.5h of stroke symptom onset. Recently, endovascular therapies have been proposed to extend and enhance stroke outcomes by targeting large vessel occlusions. Different radiologic methods, time windows, and treatment tools have delineated differences between trials. Overall, intravenous thrombolysis remains the treatment of choice for all acute ischemic stroke patients, with a small subset benefiting from additional endovascular therapy. Endovascular therapy remains a viable singular option for patients with large vessel occlusion unable to receive thrombolysis.